Analysts Set Expectations for NTLA Q3 Earnings
Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) – Stock analysts at HC Wainwright issued their Q3 2025 earnings per share estimates for shares of Intellia Therapeutics in a report issued on Wednesday, March 5th. HC Wainwright analyst M. Kapoor anticipates that the company will post earnings of ($1.48) per share for the quarter. HC Wainwright […]
